arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Whitehawk Therapeutics, Inc.

WHWK
$3.84 ▼ -0.21 (-5.19%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
70 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Whitehawk Therapeutics, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $318.3M
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC -9.9% ↗
FCF / Share $-0.18 ↗
Trailing P/E —
Price / Book 1.2x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

70-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
— —
Net Income Profit after all expenses
$-22.19M
— 0.0% —
Operating Margin Operating profit as % of sales
-213.0%
↑ +18.6% —
FCF / Share Free cash flow per share
$-0.18
↑ +45.4% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
1
Returns ↑
30
Cash Quality ↑
95

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 70 quarters